|
JPS5238680B2
(pl)
|
1972-12-27 |
1977-09-30 |
|
|
|
US4732155A
(en)
|
1985-08-27 |
1988-03-22 |
The Children's Medical Center Corporation |
Implantable chemoattractant system
|
|
US5658894A
(en)
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
|
US5661127A
(en)
|
1995-05-01 |
1997-08-26 |
The Regents Of The University Of California |
Peptide compositions with growth factor-like activity
|
|
JP3018313B2
(ja)
|
1996-02-23 |
2000-03-13 |
雪印乳業株式会社 |
骨形成促進及び骨吸収防止剤
|
|
US6875753B1
(en)
|
1996-03-14 |
2005-04-05 |
The Governors Of The University Of Alberta |
Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
|
|
US20050101564A1
(en)
|
1996-04-02 |
2005-05-12 |
Pilarski Linda M. |
Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
|
|
ATE383875T1
(de)
|
1998-03-17 |
2008-02-15 |
Chugai Pharmaceutical Co Ltd |
Prophylaktische oder therapeutische mittel gegen entzündliche erkrankungen des verdauungstraktes enthaltend antagonistische il-6 rezeptor antikörper
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
US6720340B1
(en)
|
1999-07-28 |
2004-04-13 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Nicotine receptor agonists in stem cell and progenitor cell recruitment
|
|
BR0015367A
(pt)
|
1999-11-05 |
2002-07-23 |
Gerigene Medical Corp |
Aumento e reparo de defeitos nos tecidos moles relacionados com a idade
|
|
EP1114862A3
(de)
|
1999-11-17 |
2003-08-06 |
Switch Biotech Aktiengesellschaft |
Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
|
|
HK1052372A1
(zh)
|
2000-02-24 |
2003-09-11 |
Xcyte Therapies, Inc. |
细胞的同步刺激和富集
|
|
JP3421741B2
(ja)
|
2000-05-18 |
2003-06-30 |
筑波大学長 |
人工骨髄、血球細胞の増殖方法
|
|
US20040191246A1
(en)
|
2003-02-26 |
2004-09-30 |
Connelly Patrick R. |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
ITMI20010562A1
(it)
|
2001-03-16 |
2002-09-16 |
Marco E Bianchi |
Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari
|
|
EP1390058A2
(en)
|
2001-04-30 |
2004-02-25 |
Switch Biotech Aktiengesellschaft |
Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
|
|
DE10121254A1
(de)
|
2001-04-30 |
2002-11-07 |
Switch Biotech Ag |
MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
|
|
BR0209689A
(pt)
|
2001-05-15 |
2006-02-07 |
Long Island Jewish Res Inst |
Uso de fragmento de hmg como agente anti-inflamatório
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
KR100704158B1
(ko)
|
2001-11-19 |
2007-04-05 |
교와 핫꼬 고교 가부시끼가이샤 |
다분화능 줄기세포를 조직으로부터 말초혈로 동원하는약제
|
|
CA2469370C
(en)
|
2001-12-07 |
2014-07-08 |
Macropore Biosurgery, Inc. |
Adipose-derived cell processing unit
|
|
FR2833609B1
(fr)
|
2001-12-19 |
2004-12-03 |
Natural Implant |
Dispositif de prelevement cellulaire ou tissulaire en phase active et utilisations
|
|
DE60326453D1
(de)
|
2002-07-03 |
2009-04-16 |
Ct Cardiologico Monzino S P A |
Die verwendung von hmgb1 zur behandlung von gewebeverletzungen und/oder zur unterstützung der gewebewiederherstellung
|
|
US7553488B2
(en)
|
2002-07-05 |
2009-06-30 |
UNIVERSITé LAVAL |
Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
|
|
WO2004042033A2
(en)
|
2002-11-01 |
2004-05-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circulating stem cells and uses related thereto
|
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
|
US20040156851A1
(en)
|
2002-11-20 |
2004-08-12 |
Critical Therapeutics, Inc. |
HMGB1 combination therapies
|
|
JP2006510619A
(ja)
|
2002-11-20 |
2006-03-30 |
クリティカル セラピューティクス，インコーポレイテッド |
抗炎症剤としてのｈｍｇｂ断片の使用
|
|
US7470538B2
(en)
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
EP1579221A2
(de)
|
2003-01-03 |
2005-09-28 |
Alcedo Biotech GmbH |
Verwendungen von hmgb, hmgn, hmga proteinen
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CN1193092C
(zh)
|
2003-03-28 |
2005-03-16 |
浙江大学 |
骨髓间充质干细胞分离和体外扩增培养方法
|
|
WO2004084928A1
(en)
|
2003-03-28 |
2004-10-07 |
UNIVERSITé LAVAL |
S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
|
|
US20090069227A9
(en)
|
2003-04-29 |
2009-03-12 |
Capogrossi Maurizio C |
Use of HMGB1 to promote stem cell migration and/or proliferation
|
|
CA2524950A1
(en)
|
2003-05-07 |
2004-12-02 |
La Jolla Institute For Molecular Medicine |
Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid
|
|
US20050014255A1
(en)
|
2003-05-29 |
2005-01-20 |
Board Of Regents, The University Of Texas System |
Stem cells for clinical and commercial uses
|
|
US20060183667A1
(en)
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
AU2004272607B2
(en)
|
2003-09-11 |
2008-11-06 |
Cornerstone Therapeutics Inc. |
Monoclonal antibodies against HMGB1
|
|
ITRM20040058A1
(it)
|
2004-02-03 |
2004-05-03 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
|
|
US20090062187A1
(en)
|
2004-07-20 |
2009-03-05 |
Marco Bianchi |
Use of Hmgb1 for Wound Healing
|
|
MX2007001155A
(es)
|
2004-07-29 |
2007-08-14 |
Creabilis Therapeutics Spa |
Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
|
|
CA2579094C
(en)
|
2004-09-03 |
2014-12-02 |
Creabilis Therapeutics S.P.A. |
Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1
|
|
JP2008520552A
(ja)
|
2004-10-22 |
2008-06-19 |
メディミューン，インコーポレーテッド |
Ｈｍｇｂ１に対する高親和性の抗体およびその使用法
|
|
KR100593397B1
(ko)
|
2004-10-27 |
2006-06-28 |
한국원자력연구소 |
중배엽 줄기세포 및/또는 ｐ 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
|
|
WO2006047820A1
(en)
|
2004-11-01 |
2006-05-11 |
Newsouth Innovations Pty Limited |
Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
|
|
ITRM20050032A1
(it)
|
2005-01-21 |
2006-07-22 |
Marco E Bianchi |
Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
|
|
WO2006080434A1
(ja)
|
2005-01-27 |
2006-08-03 |
Japan Health Sciences Foundation |
間葉系幹細胞を含む細胞シート
|
|
US20080171951A1
(en)
|
2005-03-23 |
2008-07-17 |
Claude Fell |
Integrated System for Collecting, Processing and Transplanting Cell Subsets, Including Adult Stem Cells, for Regenerative Medicine
|
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
|
US20100280493A1
(en)
|
2005-06-23 |
2010-11-04 |
Asha Nayak |
Methods and Systems for Treating Injured Cardiac Tissue
|
|
WO2007011606A2
(en)
|
2005-07-18 |
2007-01-25 |
Critical Therapeutics, Inc. |
USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
|
|
WO2007015546A1
(ja)
|
2005-08-04 |
2007-02-08 |
Genomix Co., Ltd |
間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
|
|
WO2007031100A1
(en)
|
2005-09-14 |
2007-03-22 |
Ostini, Marco |
Active immunotherapy of life-threatening systemic inflammation
|
|
WO2007061762A2
(en)
|
2005-11-18 |
2007-05-31 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt And Human Services |
Non-viral gene delivery complex
|
|
US20080311122A1
(en)
|
2005-11-28 |
2008-12-18 |
Medimmune, Llc |
Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
|
|
CA2640087A1
(en)
|
2006-01-25 |
2007-08-02 |
Mount Sinai School Of Medicine |
Methods and compositions for modulating the mobilization of stem cells
|
|
WO2007130725A2
(en)
|
2006-02-06 |
2007-11-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of hmgb1 for protection against ischemia reperfusion injury
|
|
JP4982739B2
(ja)
|
2006-06-01 |
2012-07-25 |
国立大学法人 東京医科歯科大学 |
ポリグルタミン病の予防・治療剤
|
|
JP5244785B2
(ja)
|
2006-08-11 |
2013-07-24 |
小野薬品工業株式会社 |
ストローマ由来因子−１（ｓｄｆ−１）に対するモノクローナル抗体
|
|
JP2010503630A
(ja)
|
2006-09-15 |
2010-02-04 |
クレアビリス・セラピューティクス・エスピーエー |
ＨＭＧＢ１のＢｏｘ−ＡおよびＨＭＧＢ１のＢｏｘ−Ａ変異体のポリマー複合体
|
|
CA2636788A1
(en)
|
2006-10-30 |
2008-05-08 |
Genomix Co., Ltd. |
Hmgb protein for use in promoting tissue regeneration
|
|
CA2629652A1
(en)
|
2007-04-24 |
2008-10-24 |
Yaojiong Wu |
Compositions for preventing or treating skin defects and methods of use thereof
|
|
US8114668B2
(en)
|
2007-05-14 |
2012-02-14 |
Cardiac Pacemakers, Inc. |
Composition for cold storage of stem cells
|
|
WO2009133943A1
(ja)
|
2008-04-30 |
2009-11-05 |
株式会社ジェノミックス |
生体内機能的細胞の高効率採取法
|
|
JP5660889B2
(ja)
|
2008-04-30 |
2015-01-28 |
株式会社ジェノミックス |
末梢循環への骨髄由来多能性幹細胞動員薬
|
|
CN102076351A
(zh)
|
2008-04-30 |
2011-05-25 |
吉诺米克斯股份有限公司 |
损伤组织的功能性再生促进药物
|
|
US9109206B2
(en)
|
2009-10-16 |
2015-08-18 |
Rutgers, The State University Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
|
WO2011049810A2
(en)
|
2009-10-20 |
2011-04-28 |
Maine Medical Center |
Compositions and methods for treating inflammation and fibrosis
|
|
KR20120135190A
(ko)
|
2009-10-28 |
2012-12-12 |
고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 |
골수 간엽계 및/또는 다능성 줄기세포의 혈중 동원(動員)에 의한 조직 재생 촉진제
|
|
US9285378B2
(en)
*
|
2010-01-29 |
2016-03-15 |
Metanomics Gmbh |
Means and methods for diagnosing heart failure in a subject
|
|
CN102247392A
(zh)
*
|
2010-05-21 |
2011-11-23 |
中国医学科学院药物研究所 |
甘草酸治疗扩张型心肌病心脏重构和心功能障碍的用途
|
|
JP5950428B2
(ja)
|
2010-08-05 |
2016-07-13 |
日東電工株式会社 |
線維化組織から正常組織を再生するための組成物
|
|
JP6012603B2
(ja)
|
2010-09-09 |
2016-10-25 |
ユニバーシティー オブ サザン カリフォルニア |
バイオフィルムを除去するための組成物および方法
|
|
EP3358011B1
(en)
|
2011-04-26 |
2020-03-04 |
StemRIM Inc. |
Peptide for inducing regeneration of tissue and use thereof
|
|
CN102443064A
(zh)
|
2011-11-03 |
2012-05-09 |
刘誉 |
一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
|
|
WO2014016417A1
(en)
|
2012-07-26 |
2014-01-30 |
Ospedale San Raffaele Srl |
Hmgb1 variants and uses thereof
|
|
KR101448800B1
(ko)
|
2012-10-24 |
2014-10-13 |
한양대학교 산학협력단 |
핵산 전달 복합체
|
|
JP6253589B2
(ja)
*
|
2012-10-25 |
2017-12-27 |
株式会社ジェノミックス |
Ｈｍｇｂ１断片を利用した新規心筋梗塞の治療法
|
|
DK2913059T3
(en)
|
2012-10-25 |
2018-06-25 |
Genomix Co Ltd |
Hitherto UNKNOWN PROCEDURE FOR TREATMENT OF SPINE INJURY USING HMGB1 FRAGMENT
|
|
GB2514424A
(en)
*
|
2013-05-25 |
2014-11-26 |
Univ Dublin |
Therapies for Cardiomyopathy
|
|
KR101636139B1
(ko)
|
2013-08-28 |
2016-07-06 |
가톨릭대학교 산학협력단 |
면역조절능이 우수한 sRAGE 과발현 간엽줄기세포 및 이를 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
|
|
GB201508337D0
(en)
|
2015-05-15 |
2015-06-24 |
Hmgbiotech S R L |
Novel peptides
|
|
AU2018213671B2
(en)
|
2017-01-27 |
2024-06-06 |
Osaka University |
Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure
|
|
JPWO2018186480A1
(ja)
|
2017-04-07 |
2020-02-20 |
株式会社ステムリム |
線維性疾患の治療薬
|
|
EP3718561A4
(en)
|
2017-12-01 |
2021-07-21 |
Stemrim Inc. |
Therapy for inflammatory bowel disease
|
|
AU2018376452A1
(en)
|
2017-12-01 |
2020-06-25 |
Osaka University |
Ectodermal mesenchymal stem cells and method for producing same
|
|
US20210024594A1
(en)
|
2018-02-08 |
2021-01-28 |
StemRIM Inc. |
Therapeutic Agent for Psoriasis
|
|
US12304933B2
(en)
|
2018-10-05 |
2025-05-20 |
StemRIM Inc. |
Disease treatment drug based on mesenchymal-stem-cell mobilization
|
|
WO2020071520A1
(ja)
|
2018-10-05 |
2020-04-09 |
株式会社ステムリム |
間葉系幹細胞の動員活性を有するペプチド
|
|
JP7555583B2
(ja)
|
2019-01-31 |
2024-09-25 |
国立大学法人大阪大学 |
母児間免疫寛容を誘導する方法
|
|
WO2021020509A1
(ja)
|
2019-07-31 |
2021-02-04 |
株式会社ステムリム |
間葉系幹細胞の増殖促進または減少抑制のための組成物
|
|
IL296982B2
(en)
|
2020-04-03 |
2026-04-01 |
Stemrim Inc |
Peptide having mesenchymal stem cell mobilizing activity
|